Search Results

By Susan Faye Dent, MD, FRCPC, FIC-OS  / March 25, 2024

Cardio-Oncology Is a Growing Subspecialty, but Where Are the Oncologists?

It has been almost 20 years since the approval of trastuzumab for the treatment of early-stage, HER2-positive breast cancer. I remember returning from the 2005 ASCO Annual Meeting excited to offer patients a treatment that led to significant improvement in clinical outcomes. However, within a short ...